LataMed AI is trading 19.57% higher at $0.48, with no clear company-specific catalyst identified for September 9, 2026.
- The latest identifiable company news is an August 19 mobile-health app development update, which predates the move and does not directly explain it.
- Broader equities and healthcare stocks are lower, so the gain does not clearly align with market or sector direction.